<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00563810</url>
  </required_header>
  <id_info>
    <org_study_id>3147K1-103</org_study_id>
    <nct_id>NCT00563810</nct_id>
  </id_info>
  <brief_title>Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of MYO-029</brief_title>
  <official_title>An Ascending Multiple Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MYO-029 Administered Intravenously as a 30-Minute Infusion to Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wyeth is now a wholly owned subsidiary of Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wyeth is now a wholly owned subsidiary of Pfizer</source>
  <brief_summary>
    <textblock>
      This is a multiple dose study assessing the safety, tolerability, pharmacokinetics and
      pharmacodynamics of an investigational new drug.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2004</start_date>
  <completion_date type="Actual">April 2006</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To assess safety and tolerability.</measure>
  </primary_outcome>
  <enrollment>72</enrollment>
  <condition>Healthy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MYO-029</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men aged 18 to 45 years inclusive on study day 1.

          -  Elderly men and women aged 65 to 80 years inclusive on study day 1.

          -  Women must be postmenopausal for &gt; or = 1 year (with estradiol &lt; 25 pg/mL and an FSH &gt;
             40 mIU/mL).

          -  Healthy as determined by the investigator on the basis of medical history, physical
             examination, vital signs, clinical laboratory test results, and 12-leave
             electrocardiogram.

          -  Elderly subjects may have stable, nonclinically significant abnormalities on physical
             examination, and laboratory evaluation.

          -  Non-smoker.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Monitor</last_name>
    <role>Study Director</role>
    <affiliation>Wyeth is now a wholly owned subsidiary of Pfizer</affiliation>
  </overall_official>
  <verification_date>November 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 21, 2007</study_first_submitted>
  <study_first_submitted_qc>November 23, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 26, 2007</study_first_posted>
  <last_update_submitted>November 23, 2007</last_update_submitted>
  <last_update_submitted_qc>November 23, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 26, 2007</last_update_posted>
  <keyword>Adult</keyword>
  <keyword>Aged</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

